Articles

Find an Article

Filter articles

Applied Filters

Showing 161 to 170 of 284 results

Putting the boot into biologic strategies

EU, UK30-06-2016Elizabeth Ward

Is it time for healthcare regulators and patent offices to limit the strategies used by existing biologic manufacturers and allow new suppliers to reach some of the world’s most lucrative healthcare systems? Elizabeth Ward of Virtuoso Legal investigates.

The value of secrecy for big pharma

EU23-06-2016Andy Sanderson and Ling Zhuang

While pharmaceutical companies are more likely to seek patent protection for their inventions, trade secrets can be useful too, particularly following two recent legislative developments, say Andy Sanderson and Ling Zhuang of Potter Clarkson.

An overview: revised biotech patent guidelines in Canada

Canada22-06-2016Jason Markwell and Stephanie Anderson

The Canadian Intellectual Property Office has updated its guidelines on procedural and examination practices, with some changes affecting biotechnology and medicinal inventions, explain Jason Markwell and Stephanie Anderson of Belmore Neidrauer.

Case report: Biocon’s breast cancer biosimilar gets green light

India16-06-2016Vikrant Rana and Sanjeeta Das

In a recent decision in India, biopharma company Biocon and its partner Mylan were allowed to continue marketing a biosimilar breast cancer drug, as Vikrant Rana and Sanjeeta Das of SS Rana report.

Optimising IP strategies: Life Sciences Law Forum preview

UK15-06-2016

Ahead of the Life Sciences Law Forum 2016, which takes place on June 23 at Etc Venues in the City of London, LSIPR previews some of the main discussion points.

A proud history of innovation

Mexico10-06-2016Nuria Becerril

IP and innovation in Mexico has come a long way, and the country’s part in international trade treaties will provide further great opportunities, says Nuria Becerril of Becerril, Coca & Becerril.

Clinical trials in Costa Rica: protecting patient privacy

Costa Rica10-06-2016María del Pilar López and Esteban Monge

There are clear rules on the use of patient data in clinical trials in Costa Rica, as well as sanctions for any breaches, explain María del Pilar López and Esteban Monge of Zürcher Lawyers.

The battle for biotech drugs in India

India09-06-2016Archana Shanker

India needs to focus more resources on evaluating applications for biologic drugs, while the biosimilar system needs to be tweaked, says Archana Shanker of Anand and Anand.

Freeing Africa from hunger

Kenya08-06-2016

Africa Harvest is working towards reducing hunger and poverty in some of the world’s poorest countries. Dr Florence Wambugu, founder of the organisation, tells LSIPR more about its work.

Best practices for patenting antibodies

08-06-2016Kene Gallois

There are several rules to watch out for when seeking patent protection for antibodies in Brazil, as Kene Gallois of Daniel Advogados reports.

Showing 161 to 170 of 284 results

LSIPR